Clinical applications of coronary sinus retroperfusion during high risk percutaneous transluminal coronary angioplasty.

OBJECTIVES: This study was designed to determine the efficacy of synchronized coronary sinus retroperfusion of arterial blood in reducing myocardial ischemia associated with the performance of high risk coronary angioplasty. BACKGROUND: Previous animal and clinical work has demonstrated the efficacy of this technique in supporting ischemic myocardium. METHODS: Twenty-one patients were randomized to alternately receive coronary sinus retroperfusion support during either the second or the third coronary angioplasty balloon inflation, after an initial unsupported brief control inflation. Myocardial ischemia was assessed by the extent of echocardiographic left ventricular wall motion abnormality, quantified ST segment deviation and hemodynamic and anginal variables during balloon inflations performed with and without coronary sinus retroperfusion support. Regional wall motion score was defined as hyperkinesia (-1), normokinesia (0), hypokinesia (+1), akinesia (+2) and dyskinesia (+3). RESULTS: A reduction in the echocardiographic left anterior descending regional wall motion score in retroperfusion-supported (1.7 +/- 2.1) versus unsupported (2.7 +/- 1.6) inflations (p < 0.05) was noted. Twelve-lead electrocardiographic monitoring revealed no additional ST segment deviation during supported (173 +/- 95 s) compared with unsupported (129 +/- 87 s) angioplasty inflations despite a significantly longer duration of supported inflations (p < 0.004). Mean and peak systolic coronary sinus pressures differed during supported inflations (21 +/- 6 and 44 +/- 13 mm Hg) versus unsupported inflations (10 +/- 4 and 16 +/- 5 mm Hg) (p < 0.001). There was no difference in hemodynamic or anginal variables. CONCLUSIONS: A reduction in ischemia as defined by wall motion abnormality during retroperfusion-supported compared with unsupported angioplasty balloon inflations was documented. No additional ST segment deviation occurred during retroperfusion-supported compared with unsupported balloon inflations despite a significantly longer duration of supported inflations. No difference in hemodynamic or anginal variables was noted.

Usefulness of thallium-201 for distinction of ischemic from idiopathic dilated cardiomyopathy.

Thallium-201 scintigraphic defects are observed in most patients with ischemic cardiomyopathy and also can be found in idiopathic dilated cardiomyopathy. To determine the ability of qualitative and quantitative perfusion parameters to differentiate these entities, thallium-201 exercise testing was performed in 51 patients with coronary arteriography referred for evaluation of severe congestive heart failure. All patients had a left ventricular ejection fraction < 35%. Thirty-one ischemic patients had coronary stenosis > 70% in > or = 1 artery, and 20 idiopathic patients had no coronary stenosis or identifiable cause of heart disease. Similar exercise capacity, ejection fraction and sex distribution were found in both groups. Ischemic patients more often had severe perfusion defects (97 vs 25%; p = 0.00001), large perfusion defects involving > or = 40% of the left ventricular contour (100 vs 80%; p = 0.01), and increased thallium-201 lung uptake (94 vs 65%, p = 0.01). Large severe defects were present in 90% of ischemic and only 5% of idiopathic patients. On quantitative analysis, the area of the thallium-201 curve less than normal was greater in ischemic than idiopathic patients (14.8 +/- 9.5% vs 3.3 +/- 2.8%; p = 0.001). The degree and severity of redistribution were similar in both groups. Multivariate analysis identified the qualitative parameters of increased thallium-201 lung uptake, severe defects and large severe defects as the only independent predictors of the presence of ischemic disease. The presence of large severe defects had a 97% predictive value for ischemic cardiomyopathy. The absence of severe defects had a 94% predictive value for idiopathic dilated cardiomyopathy.(ABSTRACT TRUNCATED AT 250 WORDS)